It’s Giving Tuesday! When we raise $100k, another $100k is unlocked GIVE NOW

FDA approves new Johnson & Johnson drug for depression

Mar 6, 2019
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an anesthetic that’s sometimes used recreationally and often known as “Special K.” Because ketamine can cause […]
Janssen Pharmaceutica

Giving Tuesday Challenge! 

If we raise $100,000 today, we’ll unlock another $100,000 from the Marketplace Investors Challenge Fund.  

Every donation makes a difference and gets us closer to the goal!